Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1145-2014Class II

Denlase: Diode Laser Therapy System and Penlase: Dental Laser Therapy System surgical powered. Surgical...

China Daheng Group, Inc. / initiated 2013-07-15 / Terminated / root cause: manufacturing process

China Daheng Group Inc. began a recall of Denlase: Diode Laser Therapy System and Penlase: Dental Laser Therapy System surgical powered. Surgical powered Laser instruments on . FDA classified it as Class II and gives the reason as "Failure to provide calibration procedures to purchasers, as required by 21 CFR 1040.11(a)(2). For example, the user manual did not contain calibration procedures for Denlase or Penlase Lasers". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1145-2014
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
China Daheng Group, Inc.
Product
Denlase: Diode Laser Therapy System and Penlase: Dental Laser Therapy System surgical powered. Surgical powered Laser instruments.
Product code
LYB
Reason for recall
Failure to provide calibration procedures to purchasers, as required by 21 CFR 1040.11(a)(2). For example, the user manual did not contain calibration procedures for Denlase or Penlase Lasers
Root cause tag
manufacturing process
FDA root cause
Radiation Control for Health and Safety Act
Action
China Daheng Group, lnc.(CDH}, ensures tha they will execute seriously their plans for the repair of their electronics products Denlase: Diode Laser Therapy System and Penlase: Dental Laser Therapy System. China Daheng Group, lnc.(CDH}, will send their updated 238 pes of Diode Laser Therapy System operation manual and 200 pes of Dental soft Tissue Laser brochure to their Distributor. They will pay all of their expense including manufacture cost and freight cost. China Daheng Group, lnc.(CDH}, will remedy these defects through changing the manuals and brochures for their distributor, purchasers and any subsequent transferee. They will make new version manuals and brochures. Then they will send them to their customers and distributor after finishing inspection by their quality department according to the procedure Denlase-Y0029A for manual and brochure inspection. CDRH approves the CAP subject to the following condition: .Notification of all dealers and purchasers is to be made within 15 working days of receipt of this letter in the manner specified in 21 CFR 1003.21 and 1003.22. This office and the Food and Drug Administration (FDA) district office coordinator noted below are to be included in the notification.
Quantity in commerce
238
Distribution
CA, KS, IL, PA, NJ, WI, WY, KY, FL and NY India, Indonesia, Turkey, Denmark, and France,
Product codes and lots
Denlase and Penlase Dental Laser Systems.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1145-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1145-2014Class IITerminatedVoluntary: Firm initiated